• Home
  • Stock
  • Sandu Pharmaceuticals Fundamental Analysis
  • Sandu Pharmaceuticals Fundamental Analysis

Sandu Pharmaceuticals fundamental analysis

SANDUPHQ

HealthcareSmall

44.4

0.70 (1.60%)
Last updated on 10 Nov, 2025 | 10:03 IST
BUYSELL

The current prices are delayed, login to your account for live prices

Sandu Pharmaceuticals Fundamentals

P/E Ratio

27.2

P/B Ratio

1

Div. Yield

1.83

Sector P/E

36.99

Sector P/B

3.63

Sec. Div. Yield

0.56

  • Sandu Pharmaceuticals Fundamentals is currently trading with a P/E Ratio of 27.2, compared to the sector average of 36.99. Its P/B Ratio stands at 1, while the sector’s is 3.63. In terms of returns, the stock offers a Dividend Yield of 1.83%, which is than the sector’s 0.56%.

Sandu Pharmaceuticals Score Card

  • Price

    Attractive

  • Growth

    Moderate

  • Quality

    Poor

  • Management

    Poor

  • On its scorecard, Sandu Pharmaceuticals reflects: Price – Attractive, Growth – Moderate, Quality – Poor, and Management – Poor. Together, these indicators provide a structured view of the company’s fundamentals.